Delivery Order SPE2DR25D3303-SPE2DR26F61D8
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet 50-1,000 mg tablets in quantities of 1,000 units, with a ceiling value of $2,012.06. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,130.90. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $4,345.92 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a non-set-aside award issued through competitive procurement. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $42,494.47 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $4,174.60. This non-set-aside competitive award is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Janumet 50-500 mg tablets (1,000 count) with a ceiling value of $2,092.51. This is a firm fixed price delivery order with no set-aside designation, classified as a competitive award. The contract is scheduled for ultimate completion on September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count units) with a ceiling value of $2,044.98. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by September 29, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, for the supply of Janumet 50-1,000 mg tablets (1,000 count) with a ceiling value of $60,770.17. The award, announced on October 29, 2025, with an ultimate completion date of October 30, 2025, was made on a firm fixed-price basis without a set-aside designation, indicating open and competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F61D8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count packaging) with a ceiling value of $6,703.49. This firm fixed-price delivery order, set to be completed by November 14, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with the federal government. The contract utilizes a non-set-aside, competitively awarded structure and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor. This delivery order is a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare systems and the Defense Health Agency worldwide. Janumet, a diabetes medication combining sitagliptin and metformin, falls within the broad therapeutic domains covered under this prime vendor agreement, supporting the DLA's pharmaceutical procurement needs for the Department of Defense and related federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 11/13/25 |